Inclusion Criteria
•	Age ≥ 18 years
•	Eastern Cooperative Oncology Group performance status ≤2
•	Life expectancy >3 months
•	Adequate bone marrow function (absolute neutrophil count ≥1500/mm3; platelets ≥100,000/mm3)
•	Adequate hepatic function (total bilirubin <1.5 x ULN; AST/ALT <2.5 x ULN)
•	Adequate renal function (creatinine clearance >60 ml/min)
•	Able to swallow tablets
•	Able to understand and willing to sign a written informed consent document

Exclusion Criteria
•	Pregnant or breastfeeding women
•	Uncontrolled hypertension
•	Active central nervous system (CNS) metastases (i.e., patients with active brain metastases should be treated with steroids and anticonvulsants to optimize CNS management before entering this trial)
•	History of myocard